Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Identifieur interne : 000A62 ( Main/Exploration ); précédent : 000A61; suivant : 000A63Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Auteurs : RBID : pubmed:22802007English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Carcinoid Tumor (metabolism), Carcinoid Tumor (pathology), Carcinoid Tumor (radionuclide imaging), Female, Fluorodeoxyglucose F18 (diagnostic use), Gene Expression Regulation, Neoplastic, Humans, Ki-67 Antigen (metabolism), Lung Neoplasms (metabolism), Lung Neoplasms (pathology), Lung Neoplasms (radionuclide imaging), Male, Middle Aged, Multimodal Imaging (methods), Neoplasm Metastasis, Octreotide (analogs & derivatives), Octreotide (diagnostic use), Positron-Emission Tomography, Prognosis, Receptors, Somatostatin (metabolism), Retrospective Studies, Tomography, X-Ray Computed, Young Adult.
- MESH :
- chemical , analogs & derivatives : Octreotide.
- chemical , diagnostic use : Fluorodeoxyglucose F18, Octreotide.
- metabolism : Carcinoid Tumor, Ki-67 Antigen, Lung Neoplasms, Receptors, Somatostatin.
- methods : Multimodal Imaging.
- pathology : Carcinoid Tumor, Lung Neoplasms.
- radionuclide imaging : Carcinoid Tumor, Lung Neoplasms.
- Adolescent, Adult, Aged, Female, Gene Expression Regulation, Neoplastic, Humans, Male, Middle Aged, Neoplasm Metastasis, Positron-Emission Tomography, Prognosis, Retrospective Studies, Tomography, X-Ray Computed, Young Adult.
Abstract
Pulmonary carcinoid (PC) tumors are rare neoplasms of the lung with good prognosis but diagnosis may be demanding since there is no exclusive modality alone to clearly differentiate a PC tumor. The purpose of this study is to establish the diagnostic features of somatostatin receptor scintigraphy (SRS), comparatively (where available) with 18FDG PET/CT (PET/CT) correlated with histopathologic findings.
DOI: 10.1007/s12149-012-0628-x
PubMed: 22802007
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.</title><author><name sortKey="Kuyumcu, Serkan" uniqKey="Kuyumcu S">Serkan Kuyumcu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Nuclear Medicine, Istanbul Medical Faculty, Istanbul University, 34390, Fatih, Istanbul, Turkey. srkuyumcu@gmail.com</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Nuclear Medicine, Istanbul Medical Faculty, Istanbul University, 34390, Fatih, Istanbul</wicri:regionArea></affiliation></author><author><name sortKey="Adalet, Isik" uniqKey="Adalet I">Isik Adalet</name></author><author><name sortKey="Sanli, Yasemin" uniqKey="Sanli Y">Yasemin Sanli</name></author><author><name sortKey="Turkmen, Cuneyt" uniqKey="Turkmen C">Cuneyt Turkmen</name></author><author><name sortKey="Ozkan, Zeynep Gozde" uniqKey="Ozkan Z">Zeynep Gozde Ozkan</name></author><author><name sortKey="Yilmazbayhan, Dilek" uniqKey="Yilmazbayhan D">Dilek Yilmazbayhan</name></author></titleStmt><publicationStmt><date when="2012">2012</date><idno type="doi">10.1007/s12149-012-0628-x</idno><idno type="RBID">pubmed:22802007</idno><idno type="pmid">22802007</idno><idno type="wicri:Area/Main/Corpus">000B82</idno><idno type="wicri:Area/Main/Curation">000B82</idno><idno type="wicri:Area/Main/Exploration">000A62</idno></publicationStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Carcinoid Tumor (metabolism)</term><term>Carcinoid Tumor (pathology)</term><term>Carcinoid Tumor (radionuclide imaging)</term><term>Female</term><term>Fluorodeoxyglucose F18 (diagnostic use)</term><term>Gene Expression Regulation, Neoplastic</term><term>Humans</term><term>Ki-67 Antigen (metabolism)</term><term>Lung Neoplasms (metabolism)</term><term>Lung Neoplasms (pathology)</term><term>Lung Neoplasms (radionuclide imaging)</term><term>Male</term><term>Middle Aged</term><term>Multimodal Imaging (methods)</term><term>Neoplasm Metastasis</term><term>Octreotide (analogs & derivatives)</term><term>Octreotide (diagnostic use)</term><term>Positron-Emission Tomography</term><term>Prognosis</term><term>Receptors, Somatostatin (metabolism)</term><term>Retrospective Studies</term><term>Tomography, X-Ray Computed</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Octreotide</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Fluorodeoxyglucose F18</term><term>Octreotide</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Carcinoid Tumor</term><term>Ki-67 Antigen</term><term>Lung Neoplasms</term><term>Receptors, Somatostatin</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Multimodal Imaging</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoid Tumor</term><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Carcinoid Tumor</term><term>Lung Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Female</term><term>Gene Expression Regulation, Neoplastic</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neoplasm Metastasis</term><term>Positron-Emission Tomography</term><term>Prognosis</term><term>Retrospective Studies</term><term>Tomography, X-Ray Computed</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Pulmonary carcinoid (PC) tumors are rare neoplasms of the lung with good prognosis but diagnosis may be demanding since there is no exclusive modality alone to clearly differentiate a PC tumor. The purpose of this study is to establish the diagnostic features of somatostatin receptor scintigraphy (SRS), comparatively (where available) with 18FDG PET/CT (PET/CT) correlated with histopathologic findings.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">22802007</PMID><DateCreated><Year>2012</Year><Month>11</Month><Day>26</Day></DateCreated><DateCompleted><Year>2013</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1864-6433</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>9</Issue><PubDate><Year>2012</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Annals of nuclear medicine</Title><ISOAbbreviation>Ann Nucl Med</ISOAbbreviation></Journal><ArticleTitle>Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.</ArticleTitle><Pagination><MedlinePgn>689-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12149-012-0628-x</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Pulmonary carcinoid (PC) tumors are rare neoplasms of the lung with good prognosis but diagnosis may be demanding since there is no exclusive modality alone to clearly differentiate a PC tumor. The purpose of this study is to establish the diagnostic features of somatostatin receptor scintigraphy (SRS), comparatively (where available) with 18FDG PET/CT (PET/CT) correlated with histopathologic findings.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-one patients who underwent SRS with 111In-octreotide and were diagnosed as having PC tumors were retrospectively studied. Thirteen patients were performed PET/CT. Primary tumour size, Ki-67 indexes, image analysis data of SRS and PET/CT including maximum standardized uptake values (SUVmax) together with false negative, false positive, true positive and true negative lesions were documented and discussed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven (52.4%) patients were typical (TC) and 10 (47.6%) were atypical carcinoids (AC) with mean Ki-67 indexes of 2.1 and 24%, respectively. Patients underwent SRS for solitary pulmonary nodule (SPN) characterization (n = 12) and determination of disease extension (n = 9). Overall sensitivity and specificity of SRS in the detection of primary tumour, lymph nodes (LN) and distant metastasis (DM) were 76 and 97 %, respectively, whereas, positive and negative predictive values were 95 and 86 %. PET/CT was performed for determining disease spread (n = 3) and metabolic characterization (n = 10) of SPNs. Mean SUVmax in the primary pulmonary lesion in TCs and ACs were 2.9 ± 0.8 and 7.9 ± 5.4, respectively. Nodal involvement (n = 5) and DM (n = 3) were also detected. Sensitivity and specificity of PET/CT in the detection of primary tumour, LNs and DM were 85 and 89.4 %, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SRS is useful in the diagnosis and monitoring of PC tumors when incorporated with 18FDG PET/CT as a primary staging tool particularly in the determination of disease spread.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuyumcu</LastName><ForeName>Serkan</ForeName><Initials>S</Initials><Affiliation>Department of Nuclear Medicine, Istanbul Medical Faculty, Istanbul University, 34390, Fatih, Istanbul, Turkey. srkuyumcu@gmail.com</Affiliation></Author><Author ValidYN="Y"><LastName>Adalet</LastName><ForeName>Isik</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Sanli</LastName><ForeName>Yasemin</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Turkmen</LastName><ForeName>Cuneyt</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ozkan</LastName><ForeName>Zeynep Gozde</ForeName><Initials>ZG</Initials></Author><Author ValidYN="Y"><LastName>Yilmazbayhan</LastName><ForeName>Dilek</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType>Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Ann Nucl Med</MedlineTA><NlmUniqueID>8913398</NlmUniqueID><ISSNLinking>0914-7187</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Ki-67 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Receptors, Somatostatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>indium-111-octreotide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance>Fluorodeoxyglucose F18</NameOfSubstance></Chemical><Chemical><RegistryNumber>RWM8CCW8GP</RegistryNumber><NameOfSubstance>Octreotide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Carcinoid Tumor</DescriptorName><QualifierName MajorTopicYN="N">metabolism</QualifierName><QualifierName MajorTopicYN="N">pathology</QualifierName><QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Fluorodeoxyglucose F18</DescriptorName><QualifierName MajorTopicYN="Y">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Ki-67 Antigen</DescriptorName><QualifierName MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName MajorTopicYN="N">metabolism</QualifierName><QualifierName MajorTopicYN="N">pathology</QualifierName><QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Multimodal Imaging</DescriptorName><QualifierName MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Octreotide</DescriptorName><QualifierName MajorTopicYN="Y">analogs & derivatives</QualifierName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Receptors, Somatostatin</DescriptorName><QualifierName MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="aheadofprint"><Year>2012</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1007/s12149-012-0628-x</ArticleId><ArticleId IdType="pubmed">22802007</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A62 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A62 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:22802007
|texte= Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22802007" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a IndiumV2
| This area was generated with Dilib version V0.5.76. |  |